Clinica    Scrip    Scrip Regulatory Affairs    Scrip Clinical Research    Animal Pharm   
Email ID
Password
Forgotten password?
Sign me in automatically next time
Home
Market Sector
Business
Policy & Regulation
Regions
Deals
|
M & A
|
Financials
|
Funding
|
Legal
|
Start-ups & SMEs
|
Market Monitor
|
clinica
Business
Quarterly results round-up: Boston still on road to recovery, Thermo Fisher and Zimmer solid
28 July 2011
Boston Scientific has continued to grow during its second fiscal quarter, helping to allay concerns sparked by CEO Ray Elliott's planned departure. He announced in May that he intends to retire at the end of the year, fuelling fears that the ...
 
Cancer dx collaborations pile up for Proteome Sciences
14 July 2011
Paving the way for future revenue growth, UK proteomics specialist Proteome Sciences has forged collaboration deals with two US research centres to develop new tests for the cancer market. The most recent collaboration, announced today, is with the ...
Gyros enlists GE to distribute immunoassay to Japan's biopharma market
14 July 2011
Gyros, which specialises in immunoassays to aid the development of drugs and vaccines, is further strengthening its global footprint by making GE Healthcare the sole distributor of its products in Japan. Uppsala, Sweden-based Gyros already had ...
 
Quarterly results round-up: Boston still on road to recovery, Thermo Fisher and Zimmer solid
28 July 2011
Boston Scientific has continued to grow during its second fiscal quarter, helping to allay concerns sparked by CEO Ray Elliott's planned departure. He announced in May that he intends to retire at the end of the year, fuelling fears that the ...
Quarterly results round-up: Alere and Qiagen slash guidance after challenging Q2
28 July 2011
Diagnostics firm Alere has cut its full-year financial guidance to $2.50-2.60 per diluted share, after being hit by lower-than-expected revenues from its health management business. Sales in the unit were down to $135.6m in the second quarter, ...
 
NeoStem raises $16.5M as it continues to shift its focus to cell therapy
22 July 2011
NeoStem, the New York-based cell therapy company, plans to raise $16.5m through the sale of 13.8 million share-and-warrant units at $1.20 per unit, a considerable discount to the 18 July stock closing price of $1.32. Each unit comprises a share and ...
Mauna Kea launches IPO to fund microscopic imaging technology
21 June 2011
French endomicroscopy specialist Mauna Kea Technologies is looking to raise around €39m ($56m) in its initial public offering on the NYSE Euronext exchange in Paris. The proceeds will enable the firm to ramp up worldwide sales of its flagship ...
 
Single application process for trans-Tasman patents planned for early 2013
21 July 2011
The governments of New Zealand and Australia have agreed on a new trans-Tasman plan to implement a single patent application and examination process for both countries that would provide inventors with a faster, cheaper and more streamlined patent ...
European Commission outlines new patent court to rescue single patent talks
22 June 2011
The European Commission has produced a new proposal for an EU patents court that it hopes will address the legal objections raised by the Court of Justice of the EU and finally allow the creation of the single EU patent. On 30 May, the court ...
 
Michael Mussallem: how innovations will spur cardio industry
15 September 2009
Joseph Harvey

It is not yet apparent what the next game-changing technology in the cardiovascular market will be, says Edwards Lifesciences ’ CEO Michael Mussallem. “Currently people are projecting moderate growth for the market. What I would suggest is ...

 
Successor at Medtronic must choose how to ride out the bumps
23 February 2011
Ashley Yeo

Bill Hawkins’ yet-to-be-appointed successor at Medtronic may be taking over at what is seen as a bad time for the group and the CRM/cardiovascular industry. But the burning question is who will the new chairman and CEO be? The announcement yesterday ...

 
Successor at Medtronic must choose how to ride out the bumps
23 February 2011
Bill Hawkins’ yet-to-be-appointed successor at Medtronic may be taking over at what is seen as a bad time for the group and the CRM/cardiovascular industry. But the burning question is who will the new chairman and CEO be? The announcement yesterday ...
 Quarterly results round-up: St Jude and Quest cut jobs to re...   St Jude picks up Medtronic's GPO slack with new contract...
Management skills put to the test in a maturing market
10 September 2010
A sobering evaluation of the medtech sector is given by Morgan Stanley Research in a briefing paper issued today. In “Medtech 2.0 – a new map for a mature sector”, analysts at the US-based investment house argue that the days of heady growth and ...
New Stock Tracker: AGA fronts possible IPO revival
28 October 2009
Stock highlight: AGA Medical (AGAM) More IPOs took place in the US during the third quarter of 2009 than in the entire first half of the year. Analysts from Ernst & Young have described the activity as “tremendous”, saying that this resurgence would ...

Clinica's MedTech Ventures: Issue 36
28 October 2009

I recently visited Norway with senior business reporter Joseph Harvey to uncover some of the hidden medtech gems there. These were not too hard to find, considering that the country's public healthcare system – which is strongly supportive of ...

 
 
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Market Sector
Business
Policy & Regulation
Regions
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Clinica
Scrip
Scrip Regulatory Affairs
Scrip Clinical Research
Animal Pharm